monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
Published 6 years ago • 173 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
8:39
final overall survival analysis of monarch 1
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
6:15
abemaciclib with hormone therapy for hr mbc
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
3:26
emerging role of abemaciclib for hr advanced breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
4:19
monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
-
1:19
advantages to treating hr patients with breast cancer with abemaciclib